Free Trial

SQZ Biotechnologies (SQZ) Competitors

SQZ Biotechnologies logo
$0.04 0.00 (0.00%)
As of 04/28/2025

SQZ vs. SGLY, CISS, PSIG, USDP, MOND, AIRTP, ATCOL, BLDEW, RA, and HXHX

Should you be buying SQZ Biotechnologies stock or one of its competitors? The main competitors of SQZ Biotechnologies include Singularity Future Technology (SGLY), C3is (CISS), PSI Group (PSIG), USD Partners (USDP), Mondee (MOND), Air T (AIRTP), Atlas (ATCOL), Blade Air Mobility (BLDEW), Brookfield Real Assets Income Fund (RA), and Haoxin (HXHX). These companies are all part of the "transportation" industry.

SQZ Biotechnologies vs.

Singularity Future Technology (NASDAQ:SGLY) and SQZ Biotechnologies (NYSE:SQZ) are both small-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability, community ranking, media sentiment and dividends.

Singularity Future Technology has a net margin of -132.89% compared to SQZ Biotechnologies' net margin of -369.96%. Singularity Future Technology's return on equity of -25.97% beat SQZ Biotechnologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Singularity Future Technology-132.89% -25.97% -17.65%
SQZ Biotechnologies -369.96%-119.83%-59.90%

4.1% of Singularity Future Technology shares are held by institutional investors. Comparatively, 38.5% of SQZ Biotechnologies shares are held by institutional investors. 10.2% of Singularity Future Technology shares are held by company insiders. Comparatively, 16.0% of SQZ Biotechnologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Singularity Future Technology has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500. Comparatively, SQZ Biotechnologies has a beta of 2.34, meaning that its stock price is 134% more volatile than the S&P 500.

SQZ Biotechnologies received 10 more outperform votes than Singularity Future Technology when rated by MarketBeat users.

CompanyUnderperformOutperform
Singularity Future TechnologyN/AN/A
SQZ BiotechnologiesOutperform Votes
10
66.67%
Underperform Votes
5
33.33%

Singularity Future Technology has higher earnings, but lower revenue than SQZ Biotechnologies. Singularity Future Technology is trading at a lower price-to-earnings ratio than SQZ Biotechnologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Singularity Future Technology$2.26M1.74-$5.11M-$0.72-1.30
SQZ Biotechnologies$18.16M0.06-$79.46M-$2.61-0.02

In the previous week, Singularity Future Technology had 1 more articles in the media than SQZ Biotechnologies. MarketBeat recorded 1 mentions for Singularity Future Technology and 0 mentions for SQZ Biotechnologies. Singularity Future Technology's average media sentiment score of 1.43 beat SQZ Biotechnologies' score of 0.00 indicating that Singularity Future Technology is being referred to more favorably in the media.

Company Overall Sentiment
Singularity Future Technology Positive
SQZ Biotechnologies Neutral

Summary

Singularity Future Technology beats SQZ Biotechnologies on 8 of the 14 factors compared between the two stocks.

Get SQZ Biotechnologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for SQZ and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SQZ vs. The Competition

MetricSQZ BiotechnologiesBiological Products IndustryMedical SectorNYSE Exchange
Market Cap$1.18M$2.97B$5.56B$19.21B
Dividend YieldN/A1.87%5.09%4.00%
P/E Ratio-0.0230.5222.6833.45
Price / Sales0.06494.70404.2829.18
Price / CashN/A168.6838.1817.52
Price / Book0.023.216.794.55
Net Income-$79.46M-$72.35M$3.22B$1.02B
7 Day PerformanceN/A13.48%3.37%2.25%
1 Month PerformanceN/A12.33%6.95%2.90%
1 Year PerformanceN/A-23.51%16.12%4.62%

SQZ Biotechnologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SQZ
SQZ Biotechnologies
N/A$0.04
flat
N/AN/A$1.18M$18.16M-0.021,620
SGLY
Singularity Future Technology
1.3984 of 5 stars
$0.64
-1.2%
N/A-80.4%$2.70M$2.26M-0.8940Positive News
CISS
C3is
0.8703 of 5 stars
$3.25
-3.0%
N/A-80.4%$2.30M$42.30M0.06N/AShort Interest ↑
News Coverage
PSIG
PSI Group
N/A$0.40
-6.3%
N/AN/A$1.46M$112.32M0.0033Gap Down
USDP
USD Partners
N/A$0.01
+14.3%
N/A-92.4%$351,000.00$72.32M-0.0190Analyst Forecast
News Coverage
Gap Up
MOND
Mondee
1.4719 of 5 stars
N/A$3.63
+∞
N/A$87,000.00$232.97M0.001,226Upcoming Earnings
AIRTP
Air T
N/A$16.36
-0.5%
N/A+5.5%$0.00$298.22M0.00500
ATCOL
Atlas
N/A$24.11
-0.2%
N/A+2.9%$0.00N/A0.006,200Positive News
High Trading Volume
BLDEW
Blade Air Mobility
N/A$0.17
+19.3%
N/A-40.2%$0.00$248.69M0.00130Short Interest ↑
RA
Brookfield Real Assets Income Fund
N/A$12.46
-1.4%
N/A+2.8%$0.00$67.52M-113.27N/ADividend Announcement
HXHX
Haoxin
N/A$1.76
-16.2%
N/AN/A$0.00$25.71M0.0099Positive News
Gap Down

Related Companies and Tools


This page (NYSE:SQZ) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners